quinidine has been researched along with Psychomotor Agitation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, JS; Chaiyakunapruk, N; Hilmer, SN; Kongpakwattana, K; Sawangjit, R; Tawankanjanachot, I | 1 |
| Antonsdottir, IM; Keltz, M; Porsteinsson, AP; Smith, J | 1 |
| Wise, J | 1 |
| Ballard, C; Corbett, A | 1 |
| Newman, JC; Steinman, MA | 1 |
| Cummings, JL; Siffert, J | 1 |
| Garay, RP; Grossberg, GT | 1 |
3 review(s) available for quinidine and Psychomotor Agitation
| Article | Year |
|---|---|
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Dementia; Dextromethorphan; Drug Combinations; Humans; Network Meta-Analysis; Psychometrics; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2018 |
Advancements in the treatment of agitation in Alzheimer's disease.
Topics: Alzheimer Disease; Cannabinoid Receptor Agonists; Cannabinoids; Citalopram; Clinical Trials, Phase III as Topic; Dextromethorphan; Drug Combinations; Humans; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2015 |
AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.
Topics: Alzheimer Disease; Animals; Brain; Deuterium; Dextromethorphan; Drug Combinations; Humans; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Tissue Distribution; Treatment Outcome | 2017 |
4 other study(ies) available for quinidine and Psychomotor Agitation
| Article | Year |
|---|---|
Combination drug shows promise for treating agitation in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Dextromethorphan; Female; Humans; Male; Psychomotor Agitation; Quinidine | 2015 |
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches.
Topics: Alzheimer Disease; Dextromethorphan; Female; Humans; Male; Psychomotor Agitation; Quinidine | 2016 |
Dextromethorphan-Quinidine for Agitation in Alzheimer Disease.
Topics: Alzheimer Disease; Dextromethorphan; Female; Humans; Male; Psychomotor Agitation; Quinidine | 2016 |
Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply.
Topics: Alzheimer Disease; Dextromethorphan; Female; Humans; Male; Psychomotor Agitation; Quinidine | 2016 |